Cardiome Pharma (CRME) Updates on Recent Insider Transactions; CEO, COO, Others Bought Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
Cardiome Announces Recent Insider Purchases
August 16, 2016 8:02 AM EDTNASDAQ: CRME Â TSX: COM
VANCOUVER, Aug. 16, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announces that Dr. William Hunter, President and CEO, Sheila Grant, Chief Operating Officer, David McMasters, General Counsel, David Dean, VP Business Development and Investor Relations, as well as a number of members of its Board of Directors, purchased an aggregate total of 108,813 common shares of Cardiome on both the TSX and the NASDAQ on August 11, 2016, August 12, 2016 and August 15, 2016. Details of the transactions can be found on the System for Electronic Disclosure by Insiders (SEDI).... More
